BRAF and ovarian cancer: Through examining the total 75 samples, among whom 17 patients developed KRAS mutation and 26 were examined for BRAF mutation, it has been identified that BRAF mutation may lead to developing ovarian cancer in females (Turashvili et al., 2018).